NCT03049033

Brief Summary

Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues developed Neurologic Music Therapy (NMT) and found it can address many gross motor impairments and improve gait and balance. Other music therapies such as Music-supported Therapy (MST) have proven motor benefits in stroke patients through movement exercises with musical instruments. However, the pathological basal ganglia (BG) in PD brains leads to a reduced supply of those internally generated movements. In contrast, externally cued movements (eg. via a beat or a rhythm) during NMT sessions are instantaneously entrained to the period of a rhythmic stimulus possibly without involvement of the BG. The underlying idea is that rhythm is the essential component relating music specifically to motor behavior. The mechanism of action is called "rhythmic entrainment" where one system's motion or signal frequency entrains the frequency of another system. The effect of NMT on fine motor function has not been investigated yet. Music activities are important in the lives of many older adults. Notably, the use of music has been associated with increased well-being for older adults, as it fosters social connection and mood regulation. Furthermore, many musical activities have limited physical demands, making them attainable for individuals who are living with mobility impairments or other physical restrictions. Based on the literature and the investigators preliminary studies, the investigators propose to test the efficacy of Neurologic Music Therapy in comparison to Music Supported Therapy and Occupational Therapy (OT) as standard of care on adults in the Parkinson's spectrum. The investigators have defined a working plan using different musical instruments and growing tempo to specifically improve fine motor movements.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 9, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

April 26, 2017

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 3, 2024

Status Verified

January 1, 2024

Enrollment Period

7.7 years

First QC Date

February 2, 2017

Last Update Submit

January 2, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Clinical Outcome: Motor 1 (change in the Grooved Pegboard Test)

    First motor outcome will be a change in the Grooved Pegboard Test.

    Baseline and 5 weeks

  • Quality of Life (QOL) Outcome: QOL 1 (change in the 39-Item Parkinson's Disease)

    First QOL outcome will be a change in the 39-Item Parkinson's Disease Questionnaire.

    Baseline and 5 weeks

  • Mechanistic Outcome: Neurophysiology 1 (change in motor beta and gamma power using Magnetoencephalography)

    Our first mechanistic outcome will be a change in cortical motor beta and gamma power using Magnetoencephalography.

    Baseline and 5 weeks

  • Mechanistic Outcome: Neurophysiology 2 (change in auditory-motor functional connectivity using Magnetoencephalography)

    Our second neurophysiology outcome will be a change in auditory-motor functional connectivity using Magnetoencephalography

    Baseline and 5 weeks

Secondary Outcomes (4)

  • Clinical Outcome: Motor 2 (change in the Unified Parkinson Disease Rating Scale Part III)

    Baseline and 5 weeks

  • Clinical Outcome: Motor 3 (change in the Finger-Thumb opposition from the Neurological Evaluation Scale)

    Baseline and 5 weeks

  • Quality of Life (QOL) Outcome: QOL 2 (change in the Clinical Global Impression - Improvement Scale)

    Baseline and 5 weeks

  • Quality of Life (QOL) Outcome: QOL 3 (change in the Hospital Anxiety and Depression Scale)

    Baseline and 5 weeks

Study Arms (4)

Neurologic Music Therapy (NMT)

EXPERIMENTAL

Neurologic Music Therapy is a 5-week intervention using different musical instruments and auditory cues to specifically improve fine motor movements.

Other: Neurologic Music Therapy

Occupational Therapy (OT)

ACTIVE COMPARATOR

Standard of care occupational therapy uses traditional motor training.

Other: Occupational Therapy

Waitlist Control

NO INTERVENTION

Participants assigned to the waitlist-control condition will not immediately receive services. The no-treatment duration for these participants is yoked to the amount of time their respective NMT- and OT-condition participants receive services (5 weeks). After the wait period, these participants will then be randomized to receive either NMT, MST or OT sessions.

Music Supported Therapy (MST)

ACTIVE COMPARATOR

Music Supported Therapy uses musical instruments to train fine motor movements.

Other: Music Supported Therapy

Interventions

Neurologic Music Therapy uses rhythms to change brain activity and function.

Neurologic Music Therapy (NMT)

Occupational Therapy uses traditional motor training.

Occupational Therapy (OT)

Music Supported Therapy uses musical instruments to train fine motor movements.

Music Supported Therapy (MST)

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 45 to 85
  • Diagnosis of Parkinson's Disease using the UK Brain Bank Criteria
  • Fine motor impairments (if available, scores 2 and higher on the UPDRS motor examination part III.23 and 24)
  • Medication stable for at least 30 days.

You may not qualify if:

  • Features suggestive of other causes of parkinsonism, including cerebrovascular disease or history of major head trauma
  • Inability to move fingers or hands
  • Hoehn and Yahr stage 4 and higher
  • Ferrous metal implants which may interfere with the MEG data acquisition and/or be an MRI safety concern
  • Dementia
  • Participants engaged in other research studies involving music therapies
  • Participants whose insurance does not cover Occupational Therapy costs or who have no insurance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver

Aurora, Colorado, 80045, United States

RECRUITING

Related Publications (1)

  • Buard I, Lattanzio L, Stewart R, Thompson S, Sjoberg K, Hookstadt K, Morrow M, Holden SK, Sillau S, Thaut M, Kluger B. Randomized controlled trial of neurologic music therapy in Parkinson's disease: research rehabilitation protocols for mechanistic and clinical investigations. Trials. 2021 Aug 28;22(1):577. doi: 10.1186/s13063-021-05560-7.

MeSH Terms

Conditions

Parkinson Disease

Interventions

Occupational Therapy

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Isabelle Buard, PhD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2017

First Posted

February 9, 2017

Study Start

April 26, 2017

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

January 3, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

De-identified data will be made available to the scientific community upon request. Data sharing will include motor tests, questionnaires and MEG raw data.

Locations